sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> pharmaceutical contract manufacturing market

report

Pharmaceutical Contract Manufacturing Market, by Types (Active Pharmaceutical Ingredients, Finished Dosage Forms, Intermediates), Formulations (Solid Formulations, Semi-Solid Formulations and Liquid Formulations) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC177 November 2016 100 FREE 10% CUSTOMIZATION

Global Pharmaceutical Contract Manufacturing Market worth USD 60.91 billion in 2016 and expected to reach USD 89.80 billion by 2022, at a CAGR of 6.7% from 2016 to 2022.

The objective of this report is to describe the market trends and revenue forecasts for the pharmaceutical contract manufacturing market for the next five years. It focuses on defining and describing the key influencing factors for the growth of the market. It also offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by the key market players. It also focuses on the key drivers, restraints, opportunities and challenges in the pharmaceutical contract manufacturing market. The scope of this report covers the pharmaceutical contract manufacturing market by its major segments which include the types, formulations, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Market size and forecast estimates for all type and formulation segment for all the years from 2014 to 2022
  • Market estimates for four geographic and twelve regional segments
  • In-depth analysis of all the market dynamics that are expected to impact the market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players in the market

KEY PREMIUM INDUSTRY INSIGHTS

  • Rapid increase in the healthcare spending is improving access to quality healthcare, which is driving the pharmaceutical contract manufacturing market.
  • Rising incidences of disease like diabetes and cancer are increasing the demand for therapeutic interventions, driving the market for pharmaceutical contract manufacturing.
  • Rapidly aging population which is more susceptible to chronic diseases, is also one of the major growth drivers for this market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s pharmaceutical contract manufacturing market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the pharmaceutical contract manufacturing market by the following segments:

  • Pharmaceutical Contract Manufacturing Market, by Types
    • Active Pharmaceutical Ingredients (APIs)
    • Finished Dosage Forms (FDF)
    • Intermediates
  • Pharmaceutical Contract Manufacturing Market, by Formulations
    • Solid Formulations
      • Tablets
      • Capsules
      • Powders
    • Semi-solid Formulations
      • Ointments
      • Gels
      • Other Semi-solid Formulations
    • Liquid Formulations
      • Syrups
      • Suspension
      • Other Liquid Formulations

KEY MARKET PLAYERS

Key players in the pharmaceutical contract manufacturing market include:

  • Aenova Holding GmbH
  • Baxter
  • Boehringer Ingelheim GmbH
  • Catalent, Inc.
  • Hospira
  • Jubilant Life Sciences Ltd.
  • Patheron
  • Recipharm AB

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Pharmaceutical Contract Manufacturing Market

TRENDING RELATED REPORT

Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Regulatory Scenario
    3. Key Merger and Acquisitions
  5. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Active Pharmaceutical Ingredients (APIs)
      2. Finished Dosage Forms (FDF)
      3. Intermediates
  6. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY FORMULATIONS
    1. Segment Share
    2. By Formulations
      1. Solid Formulations
        1. Tablets
        2. Capsules
        3. Powders
      2. Semi-solid Formulations
        1. Ointments
        2. Gels
        3. Other Semi-solid Formulations
      3. Liquid Formulations
        1. Syrups
        2. Suspension
        3. Other Liquid Formulations
  7. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Formulations
    2. Europe
      1. By Regions
        1. Germany
        2. U.K.
        3. France
        4. Rest of Europe
      2. By Types
      3. By Formulations
    3. Asia-Pacific
      1. By Regions
        1. China
        2. Japan
        3. India
        4. Rest of Asia-Pacific
      2. By Types
      3. By Formulations
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Types
      3. By Formulations
  8. COMPETITIVE LANDSCAPE
  9. KEY MARKET PLAYERS
    1. Aenova Holding GmbH
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Baxter
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Boehringer Ingelheim GmbH
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Catalent, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Hospira
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Jubilant Life Sciences Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Patheon
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Recipharm AB
      1. Overview
      2. Key Strategies
      3. Recent Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us